Loading
IARC estimates 2,900 new cancer cases and 1,558 cancer deaths in Botswana in 2024; the commonest new cancers are cervix uteri, breast and prostate. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 502 | 50.4 | Cervical cancer |
| Breast | 273 | 28.4 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 210 | 32.3 | Prostate cancer |
| Trachea, bronchus and lung | 172 | 10.7 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Oesophagus | 151 | 9.9 | Oesophageal cancer |
| Liver and intrahepatic bile ducts | 135 | 7.8 | Hepatocellular carcinoma |
| Kaposi sarcoma | 131 | 6.0 | Kaposi sarcoma |
| Colorectum | 107 | 6.4 | Colorectal cancer |
| Brain, central nervous system | 91 | 4.2 | Glioma & glioblastoma |
| Non-Hodgkin lymphoma | 91 | 4.5 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 331 | 33.9 | Cervical cancer |
| Trachea, bronchus and lung | 146 | 9.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Oesophagus | 139 | 9.0 | Oesophageal cancer |
| Liver and intrahepatic bile ducts | 104 | 6.1 | Hepatocellular carcinoma |
| Breast | 79 | 8.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Brain, central nervous system | 66 | 3.2 | Glioma & glioblastoma |
| Colorectum | 55 | 3.5 | Colorectal cancer |
| Prostate | 54 | 8.4 | Prostate cancer |
| Kaposi sarcoma | 43 | 1.9 | Kaposi sarcoma |
| Pancreas | 41 | 2.7 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in Botswana. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Botswana.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Botswana is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Botswana is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.